TheraPsil Launches Beta Version of Psilocybin Therapy Training Program Mar 2 • 5 min read TheraPsil announced the launch of its Health-Canada-approved, phase 1 psilocybin therapy training program for healthcare professionals.
MindMed Closes Acquisition of HealthMode Mar 1 • 4 min read Mind Medicine (MindMed) Inc. announced that it has closed the previously announced acquisition of HealthMode.
PsyBio Therapeutics Corp. Begins Trading on the TSX Venture Exchange Feb 26 • 3 min read PsyBio Therapeutics Corp. announced that the company will commence trading on the TSX Venture Exchange under the ticker symbol “PSYB”.
PharmaDrug Files For FDA Orphan Drug Designation For DMT Feb 25 • 5 min read PharmaDrug Inc. announced it has expanded its psychedelic pharmaceutical program with the filing of an application with the U.S. Food and Drug Administration.
NeonMind Purchases Synthetic Psilocybin from Psygen Labs Feb 24 • 6 min read NeonMind Biosciences Inc. announced that it has purchased an initial order of GMP grade psilocybin from Psygen Labs Inc.